Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950131-98-002176
Filing Date
1998-03-30
Accepted
1998-03-30 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 153571
2 BY-LAWS, AS AMENDED THROUGH 1/30/1998 EX-3.2 49788
3 FIRST AMENDMENT TO RIGHTS AGREEMENT EX-4.1(B)(B) 6072
4 CONSENT KPMG PEAT MARWICK LLP. EX-23.1 1105
5 FINANCIAL DATA SCHEDULE EX-27.1 2301
6 IMPORTANT INFORMATION ON FORWARD-LOOKING STATEMENT EX-99 13782
  Complete submission text file 0000950131-98-002176.txt   228581
Mailing Address 201 ELLIOT AVE WEST SEATTLE WA 98119
Business Address 201 ELLIOT AVE W SEATTLE WA 98119 2064678100
PATHOGENESIS CORP (Filer) CIK: 0001001186 (see all company filings)

EIN.: 911542150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27150 | Film No.: 98579691
SIC: 2834 Pharmaceutical Preparations